Groundbreaking research by Dr. Horwitz on the mechanism of action of the chemotherapy drug Taxol paved the way for it to become a blockbuster medication that is used to treat ovarian, breast, and lung cancers.

Dr. Horwitz has received numerous honors and awards, including the C. Chester Stock Award from Memorial Sloan Kettering Cancer Center, the Warren Alpert Foundation Prize from Harvard Medical School, The Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research, The American Cancer Society’s Medal of Honor, and the American Association of Cancer Research’s (AACR) Lifetime Achievement Award.

She has served as president of the AACR and is a member of the National Academy of Sciences and many other organizations and societies.